Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.

The Journal of urology - 1 May 2010

Cai Tommaso, Nesi Gabriella, Dal Canto Maurizio, Tinacci Galliano, Mondaini Nicola, Piazzini Mauro, Geppetti Pierangelo, Bartoletti Riccardo

Abstract excerpt

PURPOSE: We evaluated the role of loss of heterozygosity on the interferon-alpha locus to predict the response to bacillus Calmette-Guerin therapy in patients with nonmuscle invasive bladder cancer. MATERIALS AND METHODS: A total of 117 consecutive patients were selected, including 77 with nonmuscle invasive bladder cancer and 40 controls. Loss of heterozygosity on the interferon-alpha locus (chromosome 9p21) was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Loss of Heterozygosity

Share to Neoplasm Invasiveness

Share to Proportional Hazards Models

Share to Statistics, Nonparametric

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 20299058
DOI: 10.1016/j.juro.2009.12.105

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.PMID 20299058Read ↗

Allelic imbalance analysis using a single-nucleotide polymorphism microarray for the detection of bladder cancer recurrence.Semantic proximity Read ↗

Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.Semantic proximity Read ↗

Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma.Semantic proximity Read ↗

Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity.Semantic proximity Read ↗

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.Semantic proximity Read ↗

Low frequency of allelic loss in skin tumours from immunosuppressed individuals.Semantic proximity Read ↗

Loss of Heterozygosity at the p53, RB, DCC and APC Tumor Suppressor Gene Loci in Human Bladder CancerSemantic proximity Read ↗

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.